This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations | MicrobiomeTrials
← Back to trials NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2020-03-12Est. Completion: 2026-09-30
Enrollment target: 75 participantsLocations Children's Hospital Los Angeles, Los Angeles, California, United States University of California at Los Angeles, Los Angeles, California, United States Children's Hospital Colorado - Anschutz Medical Campus, Aurora, Colorado, United States Local Institution - 2105, Orlando, Florida, United States Local Institution - 2120, Orlando, Florida, United States Children's Healthcare of Atlanta - Egleston Hospital, Atlanta, Georgia, United States Maine Medical Center, Scarborough, Maine, United States Dana Farber Cancer Institute., Boston, Massachusetts, United States Washington University School of Medicine in St. Louis, St Louis, Missouri, United States Local Institution - 2110, New Brunswick, New Jersey, United States Local Institution - 2102, New York, New York, United States Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte, North Carolina, United States Local Institution - 2112, Cleveland, Ohio, United States Local Institution - 2114, Hershey, Pennsylvania, United States Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia, Pennsylvania, United States Other microbiome trials you might be interested in Advanced Solid Tumor Locally Advanced Solid Tumor Metastatic Solid Tumor Platinum-resistant Ovarian Cancer Post Anti-PD-1 Melanoma 2L+ Cervical Cancer Neoadjuvant Melanoma Neoadjuvant Non-Small Cell Lung Cancer Post Anti-PD-(L)1 Non-Small Cell Lung Cancer Post Anti-PD-(L)1 Small Cell Lung Cancer Third Line or Later (3L+) HER2+ Breast Cancer Second or Third Line (2L/3L) Cervical Cancer Third-line or Later (3L+) Platinum-resistant Ovarian Cancer (PROC)
TransCon IL-2 β/γ is an investigational drug being developed for treatment of locally advanced or metastatic solid tumor…
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas, Texas, United States
Baylor College of Medicine, Houston, Texas, United States
Local Institution - 2104, Houston, Texas, United States
Children's Hospital of Richmond at VCU, Richmond, Virginia, United States
Local Institution - 6104, Randwick, New South Wales, Australia
Local Institution - 6103, Westmead, New South Wales, Australia
Children's Health Queensland Hospital and Health Service, South Brisbane, Queensland, Australia
Perth Childrens Hospital, Nedlands, Western Australia, Australia
University Of Calgary, Calgary, Alberta, Canada
Stollery Children'S Hospital, Edmonton, Alberta, Canada
Children'S Hospital Of Eastern Ontario, Ottawa, Ontario, Canada
St Justine Hospital, Montreal, Quebec, Canada
Rigshospitalet - Glostrup, Copenhagen, Denmark
Local Institution - 6111, Lyon, Rhone, France
Centre Hospitalier Universitaire D'Angers, Angers, France
Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Pellegrin, Bordeaux, France
Institut d Hematologie et d Oncologie Pediatriques, Lyon, France
Hôpitaux Universitaires de Marseille Timone, Marseille, France
Local Institution - 6110, Marseille, France
Local Institution - 6112, Nantes, France
Local Institution - 6109, Paris, France
Institut Gustave-Roussy, Villejuif, France
Local Institution - 6108, Villejuif, France
Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy
Local Institution - 6113, Padova, Italy
Local Institution - 4302, Rome, Italy
Local Institution - 6114, Torino, Italy
National University Hospital, Singapore, Singapore
KK Women's and Children's Hospital, Singapore, Singapore
Local Institution - 6303, Seoul, Seodaemun-gu, South Korea
Seoul National University Hospital, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Local Institution - 6304, Seoul, South Korea
Hospital Sant Joan De Deu, Esplugues de Llobregat, Barcelona, Spain
Clínica Universidad de navarra, Pamplona, Navarre, Spain
Local Institution - 6105, Barcelona, Spain
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Hospital Infantil Universitario Nino Jesus, Madrid, Spain
Local Institution - 6106, Madrid, Spain
Clinica Universidad de Navarra, Madrid, Spain
HM Sanchinarro University Hospital, Madrid, Spain
Hospital Universitario Virgen del Rocio, Seville, Spain
Hospital Universitario Y Politecnico La Fe, Valencia, Spain
Local Institution - 6107, Valencia, Spain
Local Institution - 6202, Taipei, Taiwan
Taipei Medical University Hospital, Taipei, Taiwan
Alder Hey Children's NHS Foundation Trust, Liverpool, England, United Kingdom
Local Institution - 4403, Birmingham, United Kingdom
University Hospital of Wales, Cardiff, United Kingdom
Royal Hosp. for Children, Glasgow, United Kingdom
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Great Ormond Street Hospital For Children NHS Foundation Trust, London, United Kingdom Los Angeles, United States Est. completion Aug 2027
Bladder Cancer
Researchers are looking for new ways to treat locally advanced or metastatic urothelial cancer (UC). Current treatments …
Washington D.C., United States Est. completion Jul 27, 2029
Gastric Adenocarcinoma Gastroesophageal Junction (GEJ) Adenocarcinoma
Claudin 18.2 or CLDN18.2 is a protein found on cells in the digestive system. It is also found in some tumors. Researche…
Saint Louis Park, United States Est. completion Feb 28, 2031